Cardio-oncology and radiation oncology: How collaboration between cardiologists and oncologists can be realised in radiation oncology.

cardiac imaging cardiology oncologic imaging radiation oncology radiation oncology imaging

Journal

Journal of medical imaging and radiation oncology

ISSN: 1754-9485

Titre abrégé: J Med Imaging Radiat Oncol

Pays: Australia

ID NLM: 101469340

Informations de publication

Date de publication:
14 Jun 2024

Historique:

received: 08 01 2024

accepted: 02 06 2024

medline: 14 6 2024

pubmed: 14 6 2024

entrez: 14 6 2024

Statut: aheadofprint

Résumé

Increased survivorship, improvements in cancer treatments, and the potential for cardiac side effects from cancer treatments have resulted in increased collaboration between oncologists and cardiologists and the development of cardio-oncology clinics. This collaboration is important given its role in ensuring greater patient satisfaction, aiding teams of clinicians in making complex treatment decision, and ensuring cardiac complications are diagnosed at an early stage. The particularities of implementing this collaboration in the field of radiation oncology and how this setting is different from other areas of cardio-oncology have not been well detailed in the literature. This paper will discuss what is currently understood about the need for and role of cardio-oncology and what a cardio-oncology services involves, with a particular emphasis on patient and clinician needs in the field of radiation oncology. The literature and recent guidelines do advocate for a detailed baseline assessment of cancer patients undergoing radiotherapy, especially patients with treatment or patient risk factors that increase their risk of cancer-therapy related cardiotoxicity. Advancements in cardiac imaging techniques will be discussed as these may help to diagnose cardiac side effects of certain cancer treatments, including radiotherapy, at an early stage. A multi-disciplinary and collaborative approach is well received by patients and such an approach, guided by the aim of maintaining a patient's cancer treatment wherever possible, should be the cornerstone of cardio-oncology clinics regardless of the patient's treatment regime.

Identifiants

DOI: 10.1111/1754-9485.13724 PMID: 38874328

pubmed: 38874328

doi: 10.1111/1754-9485.13724

doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

ReFaey K, Tripathi S, Grewal SS et al. Cancer mortality rates increasing vs cardiovascular disease mortality decreasing in the world: future implications. Mayo Clin Proc Innov Qual Outcomes 2021; 5: 645–653.

Sturgeon KM, Deng L, Bluethmann SM et al. A population‐based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J 2019; 40: 3889–3897.

Barros‐Gomes S, Herrmann J, Mulvagh SL, Lerman A, Lin G, Villarraga HR. Rationale for setting up a cardio‐oncology unit: our experience at Mayo Clinic. Cardiooncol 2016; 2: 5.

Lancellotti P, Suter TM, López‐Fernández T et al. Cardio‐oncology services: rationale, organization, and implementation. Eur Heart J 2019; 40: 1756–1763.

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. [Cited 28 Nov 2023.] Available from URL: https://pubmed‐ncbi‐nlm‐nih‐gov.wwwproxy1.library.unsw.edu.au/31959335/.

White J, Byles J, Williams T, Untaru R, Ngo DTM, Sverdlov AL. Early access to a cardio‐oncology clinic in an Australian context: a qualitative exploration of patient experiences. Cardio‐Oncol. 2022; 8: 14.

Lyon AR, López‐Fernández T, Couch LS et al. 2022 ESC guidelines on cardio‐oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio‐Oncology Society (IC‐OS). Eur Heart J 2022; 43: 4229–4361.

Desai MY, Windecker S, Lancellotti P et al. Prevention, diagnosis, and management of radiation‐associated cardiac disease: JACC scientific expert panel. J Am Coll Cardiol 2019; 74: 905–927.

Armenian SH, Lacchetti C, Barac A et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol Off J Am Soc Clin Oncol 2017; 35: 893–911.

Thuny F, Bonaca MP, Cautela J. What is the evidence of the diagnostic criteria and screening of immune checkpoint inhibitor–induced myocarditis? JACC CardioOncol 2022; 4: 624–628.

Palaskas N, Lopez‐Mattei J, Durand JB, Iliescu C, Deswal A. Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment. J Am Heart Assoc 2020; 9: e013757.

Vallejo‐Camazón N, Delgado V. Cardiac surveillance in immune checkpoint inhibitor therapy: biomarkers versus imaging. JACC CardioOncol 2022; 4: 686–688.

Thuny F, Naidoo J, Neilan TG. Cardiovascular complications of immune checkpoint inhibitors for cancer. Eur Heart J 2022; 43: 4458–4468.

Hassan M, Fradley MG, Drobni ZD et al. Ventricular arrhythmias in patients with immune checkpoint inhibitor myocarditis. Eur Heart J 2021; 42 (Suppl 1): ehab724.2851.

Lu LS, Wu YW, Chang JTC et al. Risk Management for Radiation‐Induced Cardiovascular Disease (RICVD): the 2022 consensus statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC). Acta Cardiol Sin 2022; 38: 1–12.

Wright JL, Amini A, Bergom C, Milgrom SA. Summary of cardiac computed tomographic imaging in cardio‐oncology: an expert consensus document of the Society of Cardiovascular Computed Tomography. Pract Radiat Oncol 2023; 13: 488–495.

Belzile‐Dugas E, Eisenberg MJ. Radiation‐induced cardiovascular disease: review of an underrecognized pathology. J Am Heart Assoc 2021; 10: e021686.

Trivedi SJ, Tang S, Byth K et al. Segmental cardiac radiation dose determines magnitude of regional cardiac dysfunction. J Am Heart Assoc 2021; 10: e019476.

Cuomo JR, Javaheri SP, Sharma GK, Kapoor D, Berman AE, Weintraub NL. How to prevent and manage radiation‐induced coronary artery disease. Heart Br Card Soc 2018; 104: 1647–1653.

Sverdlov AL, Koczwara B, Cehic DA et al. When cancer and cardiovascular disease intersect: the challenge and the opportunity of cardio‐oncology. Heart Lung Circ 2024; 33: 558–563.

Fradley MG, Brown AC, Shields B et al. Developing a comprehensive cardio‐oncology program at a cancer institute: the Moffitt Cancer Center experience. Oncol Rev 2017; 11: 340.

Asteggiano R, Suter TM, Bax JJ. Cardio‐oncology: principles and organisational issues. [Internet] Vol. 16. [Cited 7 Sep 2023 .] Available from URL: https://www.escardio.org/Journals/E‐Journal‐of‐Cardiology‐Practice/Volume‐16/Cardio‐oncology‐principles‐and‐organisational‐issues, https://www.escardio.org/Journals/E‐Journal‐of‐Cardiology‐Practice/Volume‐16/Cardio‐oncology‐principles‐and‐organisational‐issues.

Clark RA, Marin TS, McCarthy AL et al. Cardiotoxicity after cancer treatment: a process map of the patient treatment journey. Cardiooncology 2019; 22: 14.

Zhang X, Sun Y, Zhang Y et al. Cardiac biomarkers for the detection and management of cancer therapy‐related cardiovascular toxicity. J Cardiovasc Dev Dis 2022; 9: 372.

King S, Appiah A, Bhatnagar S. Experiences in developing a cardio‐oncology clinic: a literature review. Am J Prev Cardiol 2023; 15: 100539.

Sadler D, Arnold A, Herrmann J et al. Reaching across the aisle: cardio‐oncology advocacy and program building. Curr Oncol Rep 2021; 23: 64.

Singleton AC, Redfern J, Diaz A et al. Integrating CardioOncology across the research pipeline, policy, and practice in Australia—an Australian cardiovascular Alliance perspective. Heart Lung Circ 2024; 33(5): 564–575.

Phillips WJ, Johnson C, Law A et al. Comparison of Framingham risk score and chest‐CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events. Int J Cardiol 2019; 15: 138–143.

Hecht HS, Cronin P, Blaha MJ et al. 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and Society of thoracic radiology. J Cardiovasc Comput Tomogr 2017; 11: 74–84.

Mais HE, Kay R, Almubarak H et al. Prognostic importance of coincidental coronary artery calcification on FDG‐PET/CT oncology studies. Int J Cardiovasc Imaging 2021; 37: 1479–1488.

Yu C, Ng ACC, Ridley L et al. Incidentally identified coronary artery calcium on non‐contrast CT scan of the chest predicts major adverse cardiac events among hospital inpatients. Open Heart 2021; 8: e001695.

Chiles C, Duan F, Gladish GW et al. Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: a comparison of three scoring methods. Radiology 2015; 276: 82–90.

Mitchell JD, Cehic DA, Morgia M et al. Cardiovascular manifestations from therapeutic radiation. JACC CardioOncology. 2021; 3: 360–380.

Roos CTG, van den Bogaard VAB, Greuter MJW et al. Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy? Radiother Oncol J Eur Soc Ther Radiol Oncol 2018; 126: 170–176.

Darby SC, Ewertz M, McGale P et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987–998.

Podlesnikar T, Berlot B, Dolenc J, Goričar K, Marinko T. Radiotherapy‐induced cardiotoxicity: the role of multimodality cardiovascular imaging. Front Cardiovasc Med 2022; 9: 887705.

Lai J, Hu S, Luo Y et al. Meta‐analysis of deep inspiration breath hold (DIBH) versus free breathing (FB) in postoperative radiotherapy for left‐side breast cancer. Breast Cancer 2020; 27: 299–307.

Ng ACT, Dong X, Sharma H et al. Deep inspiration breath hold and global longitudinal strain in women undergoing left‐sided breast irradiation. JACC CardioOncol 2022; 4: 136–138.

Brady B, King G, Murphy RT, Walsh D. Myocardial strain: a clinical review. Ir J Med Sci 2022; 16: 1–8.

Skyttä T, Tuohinen S, Luukkaala T, Virtanen V, Raatikainen P, Kellokumpu‐Lehtinen PL. Adjuvant radiotherapy‐induced cardiac changes among patients with early breast cancer: a three‐year follow‐up study. Acta Oncol Stockh Swed 2019; 58: 1250–1258.

Tuohinen SS, Skyttä T, Poutanen T et al. Radiotherapy‐induced global and regional differences in early‐stage left‐sided versus right‐sided breast cancer patients: speckle tracking echocardiography study. Int J Cardiovasc Imaging 2017; 33: 463–472.

Houbois CP, Nolan M, Somerset E et al. Serial cardiovascular magnetic resonance strain measurements to identify cardiotoxicity in breast cancer: comparison with echocardiography. JACC Cardiovasc Imaging 2021; 14: 962–974.

Walker V, Lairez O, Fondard O et al. Myocardial deformation after radiotherapy: a layer‐specific and territorial longitudinal strain analysis in a cohort of left‐sided breast cancer patients (BACCARAT study). Radiat Oncol 2020; 15: 201.

Das D, Asher A, Ghosh AK. Cancer and coronary artery disease: common associations, diagnosis and management challenges. Curr Treat Options Oncol 2019; 20: 46.

Pitekova B, Ravi S, Shah SV, Mladosievicova B, Heitner S, Ferencik M. The role of imaging with cardiac computed tomography in cardio‐oncology patients. Curr Cardiol Rep 2016; 18: 87.

Lancellotti P, Nkomo VT, Badano LP et al. Expert consensus for multi‐modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2013; 14: 721–740.

van Leeuwen‐Segarceanu EM, Bos WJW, Dorresteijn LDA et al. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease. Cancer Treat Rev 2011; 37: 391–403.

Andersen R, Wethal T, Günther A et al. Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma. Am J Cardiol 2010; 105: 149–152.

Takx RAP, Vliegenthart R, Schoepf UJ et al. Coronary artery calcium in breast cancer survivors after radiation therapy. Int J Cardiovasc Imaging 2017; 33: 1425–1431.

Girinsky T, M'Kacher R, Lessard N et al. Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis. Int J Radiat Oncol Biol Phys 2014; 89: 59–66.

Küpeli S, Hazirolan T, Varan A et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 2010; 28: 1025–1030.

Mulrooney DA, Nunnery SE, Armstrong GT et al. Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma. Cancer 2014; 120: 3536–3544.

Daniëls LA, Krol ADG, de Graaf MA et al. Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance. Ann Oncol Off J Eur Soc Med Oncol 2014; 25: 1198–1203.